9-(2--hydroxyethylamino)-4-methyl-1-nitroacridine and Pancreatic-Neoplasms

9-(2--hydroxyethylamino)-4-methyl-1-nitroacridine has been researched along with Pancreatic-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for 9-(2--hydroxyethylamino)-4-methyl-1-nitroacridine and Pancreatic-Neoplasms

ArticleYear
The overexpression of CPR and P450 3A4 in pancreatic cancer cells changes the metabolic profile and increases the cytotoxicity and pro-apoptotic activity of acridine antitumor agent, C-1748.
    Biochemical pharmacology, 2017, 10-15, Volume: 142

    Topics: Antineoplastic Agents; Apoptosis; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Cytochrome P-450 CYP3A; Drug Resistance, Neoplasm; Flow Cytometry; Gene Expression; Humans; Membrane Potential, Mitochondrial; NADPH-Ferrihemoprotein Reductase; Nitracrine; Pancreatic Neoplasms; Transfection; Up-Regulation

2017